| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: | 12146 | 9221 | 1569 |
 | AXELERA [Automatic translation follows] Together, let's catalyze success Creating value by developing innovative and competitive solutions for industry at the confluence of chemistry, environment and energy, and radiating internationally from a strong regional base, such is the ambition of AXELERA, the Auvergne-Rhône-Alpes chemistry-environment competitiveness cluster, created in 2005 by ARKEMA, CNRS, ENGIE, IFP Energies nouvelles, SUEZ and SOLVAY. AXELERA brings together and coordinates industry, research and training players in chemistry and the environment, around 5 strategic axes: renewable raw materials, eco-efficient plant, materials and products for industrial sectors, recycling and recyclability, preservation and restoration of natural and urban spaces. Ranked among … Sectors: | 338 | 206 | 141 |
 | CNRS Innovation Filiale du CNRS & de BPI France. 30 ans d'expertise au service de l'innovation et du transfert de technologies. CNRS Innovation, established in 1992, is a French public limited company, now a subsidiary of the CNRS at 90% and 10% Bpifrance Financement. Its mission is to transfer innovative technologies, mainly originating from the CNRS, to the industry. Its action extends from the receipt of projects to the granting of exploitation rights through consulting in Intellectual Property strategies, participation in the filing of patent applications, seeking of industrial partners, negotiating and drafting of exploitation agreements, and management of patent portfolios. CNRS … Sectors: | 502 | 157 | 348 |
 | RIVP [Automatic translation follows] Social, innovative, supportive and ethical landlord Since 1923, RIVP has been a major player in social housing in Paris. We build, renovate and manage nearly 61,000 homes in the capital and several cities in the Paris region. Our teams fully fulfill their missions for tenants through local management, based on listening, availability, solidarity and quality of service. As a project owner, RIVP is committed to the social housing policy of the City of Paris with a range of housing adapted to a variety of tenant profiles: family housing, university residences, hostels, etc. Today, the RIVP Group has … Sectors: | 362 | 206 | 170 |
 | WILCO [Automatic translation follows] Liberator of ambitions that helps women and men realize their innovative transformation projects. Challenger. Disrupter. Transform Create economic value. Positively impact society. This is what drives the WILCO teams. startups, honor loan, innovation, fundraising, Open Innovation, FrenchTech, Digital, Healthcare, Industry, Health, Fundraising, Acceleration, ETI, Large Groups, Corporate, and Intrapreneurship | 618 | 146 | 538 |
 | J'aime les Startups [Automatic translation follows] Discover the best of French startups and tips for starting your own business! Why "jaimelesstartups.fr"? Passionate about creation, business and entrepreneurship, we opened this site in January 2012 to promote startups in France and encourage exchanges between project leaders, potential investors and all experts who can express themselves freely here. Analyze everything, dissect everything, from the business model to the CSS. As is fitting, we will talk here about everything that makes up the life of a startup: from the initial idea and the business model, innovation and creativity, benchmark and development plan but also the men … Sectors: | 130 | 50 | 65 |
 | BNP Paribas The bank for a changing world BNP Paribas is a leading bank in Europe with an international reach. It has a presence in 65 countries, with more than 190,000 employees, including more than 145,000 in Europe. BNP Paribas holds leading positions in its three major operating divisions: ⚆ Commercial, Personal Banking & Services for all the Group’s retail banking networks and several specialised businesses, including BNP Paribas Personal Finance and Arval; ⚆ Investment & Protection Services for savings, investment and protection solutions; ⚆ Corporate & Institutional Banking, which is focused on corporate and institutional clients. The Group helps all its … | 5161 | 4139 | 705 |
 | SATT Paris-Saclay [Automatic translation follows] Innovation with confidence Created in 2014 and resulting from the "Investments for the Future" Program, SATT Paris-Saclay is the Technology Transfer Acceleration Company of the Paris-Saclay Cluster. A common player for both entities - Université Paris-Saclay and Institut Polytechnique de Paris - SATT has an investment capacity of 66 million euros over 10 years to finance and support the development of research work from the region and technology transfer to markets. Innovation, Technology Transfer, and Start-up Tags: SATT Network Sectors: | 227 | 107 | 147 |
 | Paris Biotech Santé [Automatic translation follows] Incubator, nursery and hotel for innovative startups in human health implemented on the Cochin campus. Paris Biotech Santé, an incubator created in 2000 by the University of PARIS CITE, ESSEC, CENTRAL SUPELEC and INSERM, selects and supports ten new innovative projects and companies per year, in the exclusive field of human health: drugs 💊 , medical devices 🏥 , e-health 💻 , AI 🧠. In 2022, the incubator is supported by the Ministry of Higher Education, Research and Innovation, the City of Paris and the Ile de France Region 🇫🇷 . Strengthening teams, helping to develop development … Sectors: | 146 | 50 | 104 |
 | Agoranov 20 ans au service des startups innovantes. #incubateur #deeptech Agoranov is an incubator for innovative startups. It has already incubated more than 540 startups, including 5 "unicorns" (valued at over one billion dollars), as well as many successful companies, such as Ÿnsect or DNA Script. Incubated startups have already managed to create more than 20,000 jobs and have raised over 5.8 billion euros from private funds. Agoranov est un incubateur de startups innovantes. Agoranov a déjà incubé plus de 450 startups, dont 5 "licornes" (startup valorisée à plus d'un milliard de dollars), ainsi que beaucoup de grands succès, comme Ÿnsect … Sectors: | 419 | 199 | 298 |
 | Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: | 1650 | 1067 | 127 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 1542 | 1407 | 58 |
 | Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: | 1747 | 1555 | 121 |
Bank